Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

Beyond Cholesterol

1989 • 6,533 citations

Book ReviewAmbulatory Pediatric Care

1989 • 2,075 citations

Endothelium‐derived relaxing and contracting factors

1989 • 2,017 citations

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

1989 • 1,914 citations

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

1984 • 1,631 citations

Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.

1987 • 534 citations

Enhanced macrophage degradation of biologically modified low density lipoprotein.

1983 • 469 citations

Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.

1985 • 388 citations

Modification of red cell membrane structure by cholesterol-rich lipid dispersions. A model for the primary spur cell defect.

1975 • 354 citations

Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta

1987 • 310 citations

Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110.

1986 • 219 citations

Lipid translocation across the human erythrocyte membrane. Regulatory factors.

1982 • 130 citations

Membrane bilayer balance and erythrocyte shape: a quantitative assessment

1985 • 124 citations

Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit.

1988 • 122 citations

Atherosclerosis, calcium, and calcium antagonists.

1985 • 106 citations

Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol.

1979 • 98 citations

Transport of biological lipophiles: effect of lipophile structure

1983 • 95 citations

Quantitative studies on lysolecithin-mediated hemolysis. Use of ether-deoxy lysolecithin analogs with varying aliphatic chain-lengths

1977 • 65 citations

Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide)

1988 • 51 citations

Evidence that lysolecithin is an important causal agent of atherosclerosis

1985 • 42 citations

Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21.

1985 • 18 citations